Teicoplanin has a long serum half-life, and therefore it takes time to reach a steady-state
concentration. An initial loading procedure has been recommended for teicoplanin to enable …

In the treatment of severe MRSA infections such as endocarditis, more than 20 mg/L of
plasma trough concentration (C min) is recommended for teicoplanin; however, in the …

Minimum inhibitory concentration (MIC) creep in vancomycin has prompted guidelines that
recommend a target trough concentration (C min) of 15–20 mg/L, and it is also considered …

Objective Teicoplanin is widely used for the treatment of severe gram-positive infection,
aiming to achieve trough serum levels of 20–60 mg/L for patients with severe infection. A …

Teicoplanin is a glycopeptide antibacterial agent that has a long serum half-life and
therefore takes time to achieve steady-state conditions. An appropriate initial dosing is …

Twenty-five published clinical studies were reviewed in which teicoplanin serum
concentrations were determined. A variety of assay methods were used, including bioassay …

Background: A trough concentration of> 20 mg/L is considered the optimal dosage of
teicoplanin required to ensure early therapeutic effects against methicillin-resistant …

Teicoplanin is used for the treatment of Methicillin‐resistant Staphylococcus aureus
infection. It has been demonstrated that conventional loading regimen was insufficient for …

Objective The objective of this study was to identify the factors influencing trough teicoplanin
concentrations (C (min)), to investigate the relationship between teicoplanin C (min) with …

Trough serum teicoplanin concentrations were compared in healthy adults following
intravenous administration of one of two regimens:(i) 12 mg/kg of body weight every 12 h for …